3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
46
Recurrence
6
Leukemia, Myeloid, Acute
5
Waldenstrom Macroglobulinemia
2
Smoldering Multiple Myeloma
2
Plasmacytoma
2
Lymphoma, Large B-Cell, Diffuse
2
Immunoglobulin Light-chain Amyloidosis
2
Carcinoma, Non-Small-Cell Lung
2
Various Advanced Cancer
1
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Paraproteinemias
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Microsatellite Unstable Colorectal Cancer
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypergammaglobulinemia
1
Hodgkin Disease
1
Amyloidosis
1
Interventions
Cyclophosphamide
21
fludarabine phosphate
18
Whole-Body Irradiation
17
Methotrexate
17
Tacrolimus
15
Peripheral Blood Stem Cell Transplantation
15
Mycophenolic Acid
13
Dexamethasone
11
Vincristine
10
Etoposide
10
Antilymphocyte Serum
10
Calcium Dobesilate
9
Busulfan
9
Rituximab
8
Doxorubicin
8
merphos
7
Filgrastim
7
Cytarabine
7
Sirolimus
6
Prednisone
6
Melphalan
6
Granulocyte Colony-Stimulating Factor
6
Cyclosporine
6
pegaspargase
5
dexamethasone acetate
5
dexamethasone 21-phosphate
5
prednylidene
4
deltacortene
4
auricularum
4
Radiotherapy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
daratumumab
×
Clear all
No trials found.